|
|
Effects of recombinant newcastle disease virus expressing IL-29(rL-29) on subcutaneous growth of A549 cells in vivo |
LIU Sha1, SU Chun-xiang2, YIN Chao-yun1, ZHAO Ying-hai1, SHAO Xiao-mei1, YAN Yu-lan1,2 |
(1. School of Medicine, Jiangsu University, Zhenjiang Jiangsu 212013; 2. Department of Respiratory, Affiliated People′s Hospital of Jiangsu University, Zhenjiang Jiangsu 212002, China) |
|
|
Abstract Objective: To explore the effect of recombinant newcastle disease virus expressing IL29(rL29) on growth of tumorbearing mouse model and the underlying mechanisms. Methods: A tumor model of human A549 into nude mice was constructed and divided randomly into three groups, including rL29 group, newcastle disease virus(NDV) group and PBS group(n=10 each). The tumor of each group were injected with rL29, NDV, PBS for 4 weeks respectively, and twice per week. Immunohistochemistry were performed to detect the expression of IL29 in tumor. Tumour volume was measured, and draw growth curves. Western blotting was performed to detect the expression of endoplasmic reticulum stress, autophagy and apoptosis associated proteins. Results: In rL29 group, IL29 protein stably expressed. Compared with NDV and PBS group,the growth of tumor in rL29 group were inhibited stronger. The expression of endoplasmic reticulum stress associated proteins such as grp78, peIF2α, CHOP and autophagy associated proteins such as Beclin1, LC3, apoptosis associated protein such as cleaved caspase3 significantly upregulated. Conclusion: rL29 effectively inhibited the growth of tumor, which may be attributed to activation of endoplasmic reticulum stress, autophagy and apoptosis.
|
Received: 01 March 2017
|
|
|
|
[1\]严玉兰,贾丽娟,刘洋,等. 重组新城疫病毒rLRVG抑制A549荷瘤鼠的瘤体生长\[J\]. 基础医学与临床,2014,34(11):1537-1542.\[2\]Bu X, Li M, Zhao Y, et al. Genetically engineered Newcastle disease virus expressing human interferonλ1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response[J]. Oncol Rep, 2016, 36(3):1393-1402.\[3\]Huang F, Wang BR, Wu YQ, et al. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer\[J\]. World J Gastroenterol, 2016, 22(35): 7999-8009.\[4\]Rehman H, Silk AW, Kane MP, et al. Into the clinic: Talimogene laherparepvec (TVEC), a firstinclass intratumoral oncolytic viral therapy\[J\]. J Immunother Cancer, 2016, 4: 53.\[5\]Wang J, Arulanandam R, Wassenaar R, et al. Enhancing expression of functional human sodium iodide symporter and somatostatin receptor in recombinant oncolytic vaccinia virus for in vivo imaging of tumors\[J\]. J Nucl Med, 2017, 58(2): 221-227.\[6\]Chai Z, Zhang P, Fu F, et al. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer\[J\]. Virol J, 2014 , 11: 84.\[7\]Li Q, Kawamura K, Okamoto S, et al. Adenovirusesmediated transduction of human oesophageal carcinoma cells with the interferonλ genes produced antitumour effects\[J\]. Br J Cancer, 2011, 105(9):1302-1312.\[8\]Guenterberg KD, Grignol VP, Raig ET, et al. Interleukin29 binds to melanoma cells inducing JakSTAT signal transduction and apoptosis\[J\]. Mol Cancer Ther, 2010, 9(2): 510-520.\[9\]Lam HY, Yusoff K, Yeap SK, et al. Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells\[J\]. Int J Med Sci, 2014, 11(12):1240-1247.\[10\]王李乐. 贝伐单抗通过内质网应激机制诱导肺癌A549细胞凋亡\[D\]. 湖南:南华大学,2015.\[11\]Bu X, Zhao Y, Zhang Z, et al. Recombinant Newcastle disease virus(rLRVG) triggers autophagy and apoptosis in gastric carcinoma cells by inducing ER stress[J]. Am J Cancer Res, 2016, 6(5):924-936. |
|
|
|